Point72 Asset Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$396K Sell
5,600
-11,100
-66% -$831K ﹤0.01% 3231
2025
Q4
$1.32M Buy
16,700
+6,200
+59% +$491K ﹤0.01% 2732
2025
Q3
$865K Buy
10,500
+9,500
+950% +$748K ﹤0.01% 1745
2025
Q2
$80.4K Buy
+1,000
New +$77.2K ﹤0.01% 2081
2025
Q1
Sell
-10,600
Closed -$868K 2339
2024
Q4
$868K Sell
10,600
-28,900
-73% -$2.4M ﹤0.01% 1505
2024
Q3
$3.26M Buy
39,500
+31,600
+400% +$2.36M 0.01% 1013
2024
Q2
$555K Buy
+7,900
New +$564K ﹤0.01% 1418

Other funds holding MET

Point72 Asset Management's MET Position: Q1 2026 in Review

Point72 Asset Management sold out of MetLife (MET) in Q1 2026, closing a stake of 969,063 shares — an estimated $72.6M sold.

Point72 Asset Management first reported a position in MET in Q3 2016 and held it in 25 quarters. The position peaked at $76.5M in Q4 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Point72 Asset Management reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 969,063 MetLife shares in Q1 2026, an estimated $72.6M.
  • Point72 Asset Management first reported a position in MetLife in Q3 2016 and held it in 25 quarters.
  • Point72 Asset Management's MetLife position peaked at $76.5M in Q4 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.